Back
Arch Capital Group Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
29
ACGL
Arch Capital Group
Last Price:
$88.17
Seasonality Move:
3.74%
Sell
41
SRPT
Sarepta Therapeutics
Last Price:
$107.93
Seasonality Move:
1.75%
Sell
29
Arch Capital Group (ACGL)
is a Sell
Is Arch Capital Group a Buy, Sell or Hold?
-
The current Arch Capital Group [ACGL] share price is $88.20. The Score for ACGL is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
ACGL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ACGL Stock Price Chart
What is Arch Capital Group's stock price today?
-
The Arch Capital Group share price today is $88.20Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACGL is experiencing selling pressure, which indicates risk of future bearish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $107.95Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
ACGL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.13 | Sell |
Relative Strength Index (14 RSI): | 36.85 | Sell |
Chaikin Money Flow: | -1498284 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (90.57 - 94.97) | Sell |
Bollinger Bands (100): | (91.34 - 107.08) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.94 | Sell |
Relative Strength Index (14 RSI): | 33.84 | Sell |
Chaikin Money Flow: | -502758 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (111.52 - 119.16) | Sell |
Bollinger Bands (100): | (114.38 - 127.78) | Sell |
ACGL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 91.02 | Sell |
20-day SMA: | 92.83 | Sell |
50-day SMA: | 92.95 | Sell |
200-day SMA: | 100.35 | Sell |
8-day EMA: | 90.48 | Sell |
20-day EMA: | 91.92 | Sell |
50-day EMA: | 93.93 | Sell |
200-day EMA: | 96.5 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 111.57 | Sell |
20-day SMA: | 114.25 | Sell |
50-day SMA: | 119.8 | Sell |
200-day SMA: | 128.55 | Sell |
8-day EMA: | 110.88 | Sell |
20-day EMA: | 113.91 | Sell |
50-day EMA: | 117.81 | Sell |
200-day EMA: | 123.39 | Sell |
Arch Capital Group Earnings Growth & ACGL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.21 per share, an increase next quarter of $0.68 per share, a decrease this year of $1.06 per share, and an increase next year of $1.77 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.
Arch Capital Group Technical Analysis
Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |